What Our Customers Say

Kineticos brought a methodical approach, experienced resources, and industry contacts to help advance our projects to a swift conclusion.

Bob Jones, CEO, Acura Pharmaceuticals

Kineticos helped accelerate our FDA submission by more than 18 months, which will save the company significant resources and enable many thousands of patients to benefit from this novel and effective therapy.

I am proud to be associated with the team Shailesh has built and the work being done at Kineticos

Kineticos are engaging and dedicated with excellent subject matter and team experience across disciplines – their life science and strategic focus have proven valuable

Kineticos was able to tailor their research to our unique technologies and market applications, and work with us to identify multiple market applications for each of our target markets and tailor their research specifically for each.

Kineticos is well positioned and works tirelessly to help develop partnerships between companies with compatibilities that ensure success. The ultimate winner is the patient, and that understanding is what makes Kineticos different – they care!

Kineticos were a delight to work with – they proved to be the perfect partner for an offshore company to get an in depth and realistic look at the US market opportunity and path to success.

Kineticos was instrumental in helping launch our startup operations inside the RTP area. We could not speak more highly of the Kineticos team and support provided to US in the early days of our endeavor.

I have had a very productive and strategic affiliation with the Kineticos team over the last 5 years. Kineticos truly are consultants, adding value and defining opportunities.

Kineticos demonstrated strong knowledge of the pharma industry, with deep connectivity among leaders, providing great insights and value.

Kineticos did an outstanding job leveraging their expertise in evaluating market opportunities and their knowledge of the project’s therapeutic area to deliver a measured assessment and recommendation that was integral to our decision making.

The insights Kineticos provided on a strategic portfolio assessment were highly actionable, and we have implemented a new strategy based on the findings – a hugely successful project!

Oliver Schacht, CEO, OpGen

Our strategic work with Kineticos provided us immense fire power to reach out to biopharmaceutical companies interested in partnering our gene, CRISPR and cell therapy programs.

Oscar Segurado, CMO, ASC Therapeutics

I highly recommend Kineticos for any company in this sector that is looking to refresh their business or venture into new business segments.

We engaged with Kineticos to research a new market for a potential investment. The insights were immediately actionable, the team was highly responsive, and communication was excellent.

David Anderson, General Partner, Ampersand

On numerous occasions the Kineticos team has promptly and diligently conducted market research through KOLs and data driven insights.”

Mark Bamforth, CEO, Arranta Bio